Amyris Inc. (AMRS) was one of the Russell 2000's biggest losers for August 28 as the stock slid 6.18% to $4.10, a loss of $0.27 per share. Starting at an opening price of $4.33 a share, the stock traded between $4.10 and $4.34 over the course of the trading day. Volume was 165,226 shares over 1,101 trades, against an average daily volume of 145,945 shares and a total float of 78,942,580.
The losses send Amyris Inc. down to a market cap of $323,664,578. In the last year, Amyris Inc. has traded between $6.11 and $2.17, and its 50-day SMA is currently $3.89 and 200-day SMA is $3.72.
For a full analysis of Amyris Inc., check out Equities.com's E.V.A. report.
Amyris Inc is a renewable products company engaged in providing sustainable alternatives to petroleum-sourced products. It developed microbial engineering and screening technologies that modify the way microorganisms process sugars.
Amyris Inc., led by CEO John Melo, has 391 employees and is headquartered in Emeryville, CA.
One of the most effective tools for tracking the market for small-cap stocks is the Russell 2000, the nation's leading small-cap index created by industry stalwart Russell Investments. Unlike the well-known Dow Jones Industrial Average (DJIA) and S&P 500, Russell's indices eschew committee selection in favor of a more objective, rules-based system for selecting index membership.
The broad-based Russell 3000, which is meant to cover the stock market as a whole, is simply the 3,000 companies with the largest market cap in the United States. The Russell 2000 is then just the bottom 2,000 companies of that index, offering a look at those small-cap companies with smaller market caps. It makes for an unbiased overview of the small-cap stocks that can help any investor get a better sense of what the market is doing and where it might be headed.
For more news on the financial markets, go to Equities.com. Also, learn more about our Small-Cap Stars. Register to become a member and leverage our proprietary research tools such as the Small-Cap Stars, and robust do-it-yourself Equities Valuation Analysis (E.V.A.) research reports.
All data provided by QuoteMedia and was accurate as of 4:30PM ET.